N
0.330
0.00 (0.27%)
| Previous Close | 0.329 |
| Open | 0.271 |
| Volume | 1,222 |
| 52 Weeks Range |
| Profit Margin | -30.70% |
| Operating Margin (TTM) | -27.69% |
| Diluted EPS (TTM) | -1.39 |
| Quarterly Revenue Growth (YOY) | 121.60% |
| Total Debt/Equity (MRQ) | 49.25% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -3.17 M |
| Levered Free Cash Flow (TTM) | -2.58 M |
| Return on Assets (TTM) | -20.77% |
| Return on Equity (TTM) | -60.08% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | NexGel, Inc Warrant | - | - |
AIStockmoo Score
-0.7
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.67 |
|
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |